【24h】

Evaluation of Innotrac Aio!Second-Generation Cardiac Troponin I Assay:The Main Characteristics for Routine Clinical Use

机译:Innotrac Aio的评估!第二代心肌肌钙蛋白I测定:常规临床用途的主要特征

获取原文
获取原文并翻译 | 示例
       

摘要

The availability of a simple,sensitive,and rapid test using whole blood to facilitate processing and to reduce the turnaround time could improve the management of patients presenting with chest pain.The aim of this study was an evaluation of the Innotrac Aio!second-generation cardiac troponin I (cTnI) assay.The Innotrac Aio!second-generation cTnI assay was compared with the Abbott AxSYM first-generation cTnI,Beckman Access AccuTnI,and Innotrac Aio!first-generation cTnI assays.We studied serum samples from 15 patients with positive rheumatoid factor but with no indication of myocardial infarction (MI).Additionally,the stability of the sample with different matrices and the influence of hemodialysis on the cTnI concentration were evaluated.Within-assay CVs were 3.2%-10.9%,and between-assay precision ranged from 4.0% to 17.2% for cTnI.The functional sensitivity (CV=20%) and the concentration giving CV of 10% were approximated to be 0.02 and 0.04,respectively.The assay was found to be linear within the tested range of 0.063-111.6 mu g/L.The correlations between the second-generation Innotrac Aio!,Access,and AxSYM cTnI assays were good (r coefficients 0.947-0.966),but involved differences in the measured concentrations,and the biases were highest with cTnI at low concentrations.The second-generation Innotrac Aio!cTnI assay was found to be superior to the first-generation assay with regard to precision in the low concentration range.The stability of the cTnI level was best in the serum,lithium-heparin plasma,and lithium-heparin whole blood samples (n=10,decrease < 10% in 24 hours at+20 deg C and at+4 deg C).There was no remarkable influence of hemodialysis on the cTnI release.False-positive cTnI values occurred in the presence of very high rheumatoid factor values,that is,over 3000 U/L.The 99th percentile of the apparently healthy reference group was <=0.03 mu g/L.The results demonstrate the very good analytical performance of the second-generation Innotrac Aio!cTnI assay.
机译:使用全血的简单,敏感和快速测试的可用性,以方便加工和减少周转时间可以改善胸痛患者的管理。本研究的目的是对Innotrac Aio的评估!第二代心肌肌钙蛋白I(CTNI)测定。与Abbott Axsym第一代CTNI,Beckman Access Accutni和Innotrac Aio进行比较Innotrac Aio!第一代CTNI测定。我们研究了15名患者的血清样品阳性类风湿因子,但没有心肌梗死(MI)的迹象。加法,评价不同基质样品的稳定性和血液透析对CTNI浓度的影响。试验CVS为3.2%-10.9%,与 - 测定精度为CTNI的4.0%至17.2%。功能敏感性(CV = 20%)和10%的CV的浓度分别为0.02和0.04。发现是线在0.063-111.6 mu g / l的测试范围内。第二代Innotrac aio之间的相关性!,访问和Axym CTNI测定良好(r系数0.947-0.966),但涉及测量浓度的差异,在低浓度下CTNI偏差最高。第二代Innotrac Aio!发现CTNI测定值优于第一代试验,关于低浓度范围的精度。CTNI水平的稳定性最佳血清,锂 - 肝素等离子体和锂 - 肝素全血样品(n = 10,在+ 20℃和+ 4℃下24小时减少<10%)。血液透析对CTNI释放没有显着影响。阳性CTNI值发生在存在非常高的类风湿因子值中,即超过3000 u / l。明显健康的参考组的第99百分位数为<=0.03μg/ l。结果表明了非常好的第二代Innotrac Aio的分析性能!CTNI测定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号